Biopharma Research, Page 6 | Maven Bio

Skip to main content

Roche's Pharmaceutical Division Performance in Q2 2024 YoY

Sep 11, 2024

Notable Biopharma Fundraises in August: Powering Promising Treatments

Sep 9, 2024

Epidemiologies of Oncology: Insights from AstraZeneca and Novartis

Sep 9, 2024

New EMA Medicine Approvals Through August 2024

Sep 4, 2024

Revolutionizing Cancer Treatment: The Emergence of mRNA Vaccines

Sep 4, 2024

Crowning Achievements: Recent Royalty Deals in BioPharma

Sep 3, 2024

BioPharma's Direct-to-Consumer Evolution

Sep 3, 2024

Atopic Dermatitis Landscape

Aug 29, 2024

How Much Do Large BioPharma Companies Spend on Capex?

Aug 29, 2024

Research your next biopharma question with Maven.

Request a trial